Literature DB >> 699908

Studies on the biosynthesis of bacterio-opsin. Demonstration of the existence of protein species structurally related to bacterio-opsin.

M Sumper, G Herrmann.   

Abstract

1. The kinetics of processing newly synthesized bacterio-opsin from the non-crystalline state within the brown membrane to the crystalline state within the purple membrane was followed by pulse-chase experiments. 2. Biosynthesis of bacterio-opsin was found to be highly resistant to RNA-synthesis inhibitors like rifampicin and ethidium bromide. In the presence of ethidium bromide, only five protein species continue to be synthesized in halobacteria, one of them being bacterio-opsin. 3. In spheroplasts, synthesis of bacterio-opsin is found to be selectively disturbed. The purple membrane isolated from spheroplasts contains new, additional protein species with apparent molecular weights of 19 000, 23 000 and 29 000. These proteins share common amino acid sequences with bacterio-opsin. 4. In the halobacterial cell membrane, two membrane proteins with apparent molecular weights of 30 000 and 36 000 were detected which are structurally related to bacterio-opsin. 5. Bacterio-opsin as well as the 30 000 Mr and 36 000-Mr proteins contain covalently bound sulphate.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 699908     DOI: 10.1111/j.1432-1033.1978.tb20917.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  3 in total

1.  Association of the halobacterial 7S RNA to the polysome correlates with expression of the membrane protein bacterioopsin.

Authors:  R Gropp; F Gropp; M C Betlach
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

Review 2.  The archaeal flagellum: a unique motility structure.

Authors:  K F Jarrell; D P Bayley; A S Kostyukova
Journal:  J Bacteriol       Date:  1996-09       Impact factor: 3.490

3.  Efficient transfection of the archaebacterium Halobacterium halobium.

Authors:  S W Cline; W F Doolittle
Journal:  J Bacteriol       Date:  1987-03       Impact factor: 3.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.